Objectives: To present the recommendations and supporting literature for RBC transfusions in critically ill children with nonhemorrhagic shock developed by the Pediatric Critical Care Transfusion and Anemia Expertise Initiative. Design: Consensus conference series of international, multidisciplinary experts in RBC transfusion management of critically ill children. Methods: The panel of 38 experts developed evidence-based, and when evidence was lacking, expert-based clinical recommendations as well as research priorities for RBC transfusions in critically ill children. The nonhemorrhagic shock subgroup included five experts. Electronic searches were conducted using PubMed, EMBASE, and Cochrane Library databases from 1980 to May 2017. Agreement was obtained using the Research and Development/UCLA Appropriateness Method. Results were summarized using the Grading of Recommendations Assessment, Development, and Evaluation method. Results: Transfusion and Anemia Expertise Initiative Consensus Conference experts developed and voted on a total of four clinical and four research recommendations focused on RBC transfusion in the critically ill child with nonhemorrhagic shock. All recommendations reached agreement (> 80%). Of the four clinical recommendations, three were based on consensus panel expertise, whereas one was based on weak pediatric evidence. In hemodynamically stabilized critically ill children with a diagnosis of severe sepsis or septic shock, we recommend not administering a RBC transfusion if the hemoglobin concentration is greater than or equal to 7 g/dL. Future studies are needed to determine optimum transfusion thresholds for critically ill children with nonhemorrhagic shock undergoing acute resuscitation. Conclusions: The Transfusion and Anemia Expertise Initiative Consensus Conference developed pediatric-specific clinical and research recommendations regarding RBC transfusion in the
S
hock is defined as inadequate oxygen delivery to meet metabolic demands and is often also referred to as "oxygen debt." Nonhemorrhagic shock, secondary to conditions such as sepsis, is a common indication for RBC transfusion with the intent to increase oxygen delivery in critically ill children (1, 2) . However, little data exist to guide RBC transfusion practice in this population, underscoring the need for ongoing prospective study in this area. The following article reviews the current literature and details regarding clinical and research recommendations for RBC transfusion in critically ill children with nonhemorrhagic shock.
METHODS
The details of the methodology are described elsewhere in this supplement of Pediatric Critical Care Medicine (3) . Briefly, we searched PubMed, EMBASE, and Cochrane Library from 1980 to December 2015, with an update in May 2017, using a combination of medical subject heading terms and text words to define concepts of RBC transfusion and nonhemorrhagic shock in children. We searched references from identified articles for additional publications. Two authors reviewed all citations independently. We used a standardized data extraction form to construct evidence tables and graded the evidence using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) system. A panel of 38 experts from 29 academic institutions in eight countries met over the course of 2 years to develop evidence-based and, when evidence was lacking, expert-based recommendations for RBC transfusion in critically ill children. Five experts coordinated the nonhemorrhagic shock subgroup. Recommendations developed and supporting literature were reviewed and scored by all panel members, using the Research and Development/UCLA Appropriateness Method. All recommendations reached agreement (> 80%). Final recommendations for RBC transfusion in critically ill children with nonhemorrhagic shock were divided into two categories: clinical recommendations and research recommendations.
RESULTS
Structured literature search identified 1,827 abstracts. Of these, 1,785 references were excluded based on the abstract. An additional 39 references were excluded based on full article review, leaving three references that were used for guideline creation. The references included are detailed in Supplemental Rationale. Prompt recognition and reversal of shock or oxygen debt remain mainstays of adult and pediatric critical care. Since RBC transfusion, as a means to potentially increase oxygen delivery, is often an integral part of early goal-directed therapy aimed at early shock reversal. In children, a single randomized controlled trial (RCT) of 102 pediatric patients with septic shock evaluated central venous oxygen saturation (Scvo 2 )-guided goal-directed therapy (4). The intervention group included continuous Scvo 2 measurement and adjusted therapies to achieve and maintain a Scvo 2 of greater than 70%. Per the guideline-based protocol, subjects in the intervention group with normal blood pressure and Scvo 2 less than 70% were administered either crystalloid infusion, inotropic support, or RBC transfusion (if the hemoglobin level was < 10 g/dL). Accordingly, the therapeutic interventions which significantly differed between the intervention and control groups within the first 6 hours of resuscitation included crystalloid infusion (28 mL/kg [20- The study demonstrated reduced 28-day mortality (11.8% vs 39.2%; adjusted odds ratio, 0.18; 95% CI, 0.05-0.69) in the intervention group, suggesting benefit to Scvo 2 -guided, goal-directed therapy. However, because the evaluated interventions were applied within a bundle, the relative effects of RBC transfusion compared with crystalloid infusion or inotropic support cannot be determined. To date, no studies have been performed to evaluate the efficacy of RBC transfusion compared with alternate methods to reverse shock or to augment oxygen delivery in this population.
RBC transfusion carries risk. Although the frequencies of blood-borne infection, hemolytic transfusion reaction, and nonhemolytic transfusion reactions are low, RBC transfusion likely also confers risk of morbidity and mortality due to transfusion-related immune modulation, dysregulated hemostasis, and transfusion-associated lung injury (5) . Critically ill patients with septic shock may be at particularly high risk of transfusion-associated complications because of their underlying states of dysregulated hemostatic and immunologic responses at the time of transfusion (6) (7) (8) (9) (10) . In a recent metaanalysis of cohort studies in critically ill septic adults, RBC transfusion was associated with increased risks of nosocomial infection, acute lung injury, and renal injury (11) . In critically ill children, RBC transfusion is associated with prolonged Pediatric Critical Care Medicine www.pccmjournal.org S123 mechanical ventilation, ICU stay, and new or progressive organ dysfunction (12) . Although prospective studies to determine relative risks and benefits of RBC transfusion compared with therapeutic alternatives to augment oxygen content or delivery are lacking, it is possible that for some children with nonhemorrhagic shock, transfusion risks may outweigh benefits.
At this time given the known risks of transfusion, it seems prudent to consider RBC transfusion as part of a more comprehensive approach to augment the ratio of oxygen delivery to oxygen demand. Future studies evaluating RBC transfusion as part of a tiered approach to shock management are needed.
The primary goal for RBC transfusion in patients with nonhemorrhagic shock and anemia is to augment arterial oxygen content in order to enhance oxygen delivery to tissues. It is therefore likely that using markers of oxygen debt and delivery to guide RBC transfusion decision-making would be superior to using hemoglobin measurements alone. Such markers would be expected to have the added advantage of assessing RBC transfusion efficacy. Although several candidate markers exist (including Scvo 2 , lactate measurements, near-infrared spectroscopy, invasive measures of oxygen consumption [Vo 2 ] and oxygen delivery, etc), clear superiority of one measure over another has yet to be determined. Accordingly, clinical trials evaluating outcomes related to the use of physiologic-based transfusion triggers in children with nonhemorrhagic have yet to be performed. Therefore, although physiologic-based triggers for RBC transfusion in the setting of shock hold promise for the future, at this time we cannot recommend one strategy over another.
Hemodynamically Unstable Children With Nonhemorrhagic Shock
Recommendation 3.3 We cannot make a recommendation regarding transfusion thresholds for critically ill children with unstable non-hemorrhagic shock. Consensus panel expertise, 100% Agreement, Median 9, Rationale. RBC transfusion strategy has not been evaluated in prospective studies of critically ill children with unstable shock. Current American College of Critical Care Medicine guidelines for hemodynamic support of pediatric and neonatal shock recommend RBC transfusion to a goal hemoglobin of greater than 10 g/dL to achieve a Scvo 2 greater than 70% (13). The recommendation is based on the study by de Oliveira et al (4) , in which a Scvo 2 -guided resuscitation (which included RBC transfusion for Scvo 2 < 70% and hemoglobin < 10 g/dL) demonstrated a significant mortality benefit compared with non-Scvo 2 -guided resuscitation-suggesting that, at least as part of a bundled goal-directed resuscitation strategy, there may be benefit to this transfusion threshold. However, as discussed above, the Scvo 2 -targeted group also received significantly greater fluid resuscitation in the first 6 hours and were more likely to have early initiation of inotropic support-both of which were likely beneficial. Thus, it is unclear whether the mortality benefit seen was related to the RBC transfusion strategy.
To date, randomized trials of liberal versus restrictive RBC transfusion practice in the acute shock setting are lacking. The only RCT in critically ill children, the Transfusion Strategies for Patients in PICUs (TRIPICU) study, excluded hemodynamically unstable children (14) . In adults, the Transfusion Requirements in Septic Shock (TRISS) trial included subjects with shock; however, the median time from ICU admission to enrollment was approximately 24 hours, and 12% of otherwise eligible subjects were excluded due to prior transfusion (15) . Thus, the effects of a restrictive transfusion strategy in the early hours of acute resuscitation remain unclear. Indeed, in a propensity score-matched retrospective analysis of an adult multicenter early goal-directed therapy registry, RBC transfusion was independently associated with improved mortality for those patients with Scvo 2 less than 70% and hemoglobin less than 10 g/dL, while inotrope infusion was not. These data suggest that RBC transfusion may be beneficial in this setting, although definite conclusions cannot be drawn due to the limitations of the retrospective study design (16) .
The rationale for RBC transfusion in the setting of unstable shock is to improve Vo 2 by augmenting hemoglobin concentration and thereby increasing oxygen delivery. Two small studies have evaluated the effects of RBC transfusion on oxygen delivery and Vo 2 in pediatric patients with septic shock-with conflicting results (17, 18) . In both studies, RBC transfusion was associated with increased oxygen delivery. In the study by Mink and Pollack (19) (n = 8), RBC transfusion was not associated with increase in Vo 2 . By contrast, the study by Lucking et al (17) (n = 7), which included only children with hyperdynamic shock and a low baseline Vo 2 , demonstrated statistically significant improvement in Vo 2 post RBC transfusion (Vo 2 112 ± 36 vs 157 ± 60 mL/min × m 2 ; p < 0.01). The pretransfusion hemoglobin in the study by Lucking et al (17) was 9.3 ± 1.4 g/dL. These studies suggest that for select children with septic shock, even in the absence of severe anemia, RBC transfusion may improve Vo 2 -although effects on clinical outcomes are unclear.
Although a specific recommendation cannot be made, until further studies are conducted, it is reasonable to consider a hemoglobin threshold that ranges between less than 7 and less than 10 g/dL as part of a comprehensive approach to improve oxygen delivery for children with unstable nonhemorrhagic shock and evidence of oxygen debt.
Hemodynamically Stabilized Children With Nonhemorrhagic Shock
Recommendation 3.4 In hemodynamically stabilized* critically ill children with a diagnosis of severe sepsis or septic shock, we recommend not administering a RBC transfusion if the Hb concentration is ≥ 7 g/dL. Weak recommendation, Low quality pediatric evidence (2C), 96% Agreement, Median 8, *Hemodynamically stabilized is defined according to inclusion criteria for the TRIPICU study: mean systolic blood pressure not less than 2 sds below the mean normal for age and cardiovascular treatments not increased within the past 2 hours (14).
Rationale. A single RCT of restrictive versus liberal transfusion strategies in critically ill children exists. The TRIPICU study was a randomized, controlled noninferiority study evaluating a liberal (transfusion threshold hemoglobin of 9.5 g/dL) versus restrictive (transfusion threshold of 7 g/dL) transfusion strategy in 637 critically ill children (14) . All patients included in the TRIPICU study were hemodynamically stabilized as defined by mean systolic blood pressure not less than 2 sds below the mean normal for age and cardiovascular treatments not increased within the past 2 hours. One-hundred thirtyseven patients with sepsis were included in TRIPICU and were analyzed as a planned subgroup analysis (19) . Of these, 40 subjects had severe sepsis (19 restrictive; 12 liberal) and 34 subjects had septic shock (13 restrictive; 21 liberal). Across the entire 137 subject cohorts (69 restrictive; 68 liberal), the proportion of patients who developed new or progressive multiple organ dysfunction was the same between groups (absolute risk reduction, 0.3%; 95% CI, -12% to +14%). PICU mortality and 28-day mortality were higher in the restrictive group (5 vs 2 deaths, p = 0.44; and 7 vs 2, p = 0.08, respectively), although the number of deaths was small and differences were not statistically significant. This does however raise the possibility of harm in the restrictive group, which should be evaluated in additional study. It is also important to consider that only a portion of the analyzed subgroup had septic shock and were on vasoactive support. The results of Karam et al (19) have yet to be verified in larger study of critically ill children with severe sepsis or septic shock, which represents an important research need.
Extrapolating from adult literature, the TRISS trial randomized 998 adults with septic shock to a transfusion threshold hemoglobin of 7 versus 9 g/dL (15) . In contrast to the TRIPICU trial, hemodynamically unstable patients were included in the TRISS trial. There were no differences in the primary outcome of 90-day mortality between groups (relative risk, 0.94; 95% CI, 0.78-1.09), suggesting that a restrictive transfusion strategy was safe within their study population. In a follow-up study, there were also no significant differences between groups in 1-year mortality or in health-related quality of life at 1 year (20) . Overall, these studies suggest that a hemoglobin threshold of 7 g/dL is safe in critically ill patients with shock, particularly once they are stabilized, although larger studies in children with shock are needed. "GRADE 2C based on downgrading for risk of bias, imprecision, and residual confounding."
RECOMMENDATIONS FOR RESEARCH Recommendations
R3.1 We recommend future studies to evaluate the utility of physiologic markers of oxygen debt and oxygen delivery in conjunction with hemoglobin-based targets to guide RBC transfusion decisions for critically ill children with non-hemorrhagic shock. Consensus panel expertise, 97% Agreement, Median 9, R3.2 We recommend future studies to determine optimum transfusion thresholds for critically ill children with nonhemorrhagic shock undergoing acute resuscitation. Consensus panel expertise, 97% Agreement, Median 9, IQR 8-9
R3.3 The relative risks, benefits and alternatives of RBC transfusion to augment oxygen delivery remain unclear and should be the subject of future studies in critically ill children with non-hemorrhagic shock. Consensus panel expertise, 97% Agreement, Median 9, R3. 4 We recommend future studies to determine long-term effects of anemia in children with non-hemorrhagic shock. Consensus panel expertise, 100% Agreement, Median 9, Rationale As discussed above, the evidence guiding RBC transfusion practice in children with nonhemorrhagic shock is limited, and many questions remain. Chief among them is whether hemoglobin levels are the most appropriate triggers for RBC transfusion, particularly for children undergoing resuscitation for acute shock. Given that the purpose for RBC transfusion in this setting is to augment oxygen delivery to match oxygen demand, it seems reasonable that measures of inadequate oxygen delivery may provide more clinically relevant transfusion triggers. Several candidate markers exist. However, it is unclear which of these markers will best predict need for transfusion, and prospective studies evaluating physiology-based markers to guide RBC transfusion decisionmaking have not been performed. Similarly, studies evaluating RBC transfusion compared with other interventions to augment oxygen delivery for those patients with demonstrated oxygen debt are needed. It is possible that the risk/benefit ratio of alternative approaches to augment oxygen delivery (e.g., augmenting inotropic support) is more favorable compared with that of RBC transfusion, although this remains an unanswered question.
Studies to date evaluating RBC transfusion practice in critically ill children have focused on short-term outcomes (14, 19, 21) . As such, relationships between RBC transfusion and longterm outcomes, including neurodevelopmental outcomes, are unknown. Because the majority of critically ill children survive their acute illness, it is increasingly important to understand effects of ICU-based interventions on long-term outcomes. Additionally, infants and children are exposed to critical illness at a time of maximal brain growth and development, underscoring the need to understand effects of RBC transfusion and other therapies on neurodevelopmental outcomes. Relevant to RBC transfusion, randomized trials of liberal versus restrictive transfusion thresholds in premature infants reveal mixed results regarding neurodevelopmental outcomes, and it is unclear which strategy may be preferred (22) (23) (24) (25) . Although the ongoing Transfusion of Prematures trial (NCT01702805) promises to shed light on this important question, it is unclear whether these findings will be generalizable to full-term infants and children in the PICU.
SUMMARY
Clinical evidence to guide RBC transfusion decision-making for children with nonhemorrhagic shock remains sparse, resulting in recommendations based on only weak evidence or consensus expert opinion. While consensus was reached with strong agreement, much work remains to answer important questions about the safety and efficacy of RBC transfusion in this patient population.
